What is Epic Pharma?
Epic Pharma is a prominent FDA-approved generic pharmaceutical company dedicated to the development, manufacturing, and distribution of high-quality, affordable medications. Their operations encompass the production of various dosage forms, including tablets, capsules, and powders, alongside offering contract manufacturing services. The company adheres to stringent quality control measures and regulatory compliance across its diverse product portfolio, which addresses key therapeutic areas such as cardiovascular, respiratory, and anti-infectives.
How much funding has Epic Pharma raised?
Epic Pharma has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for Epic Pharma?
The recent major strategic investment signals a pivotal phase for Epic Pharma, likely enabling further expansion of its manufacturing capabilities, research and development into new generic formulations, or broader market penetration. This infusion of capital is expected to bolster its competitive edge in the generic drug market, potentially leading to increased product offerings and enhanced distribution networks. The company's focus on affordability and quality positions it for sustained growth within the enterprise-level pharmaceutical landscape.
See full Epic Pharma company page
